Description
Product details
METAPROLATE H 50/12.5 is a premium antihypertensive medication formulated with Metoprolol Succinate Extended Release 50 mg and Hydrochlorothiazide 12.5 mg. This dual-action combination is intended for the treatment of hypertension (high blood pressure) in adults who require combination therapy for better blood pressure control. By combining two well-established medicines with complementary mechanisms of action, the formulation helps support long-term cardiovascular health while offering the convenience of once-daily dosing. Manufactured in GMP-certified facilities using high-quality pharmaceutical ingredients, METAPROLATE H 50/12.5 is produced under rigorous quality assurance protocols to ensure safety, efficacy, and batch-to-batch consistency. The extended-release technology allows a gradual release of Metoprolol throughout the day, providing sustained therapeutic effects and helping maintain stable blood pressure levels. Composition Brand Name: METAPROLATE H 50/12.5 Generic Name: Metoprolol Succinate Extended Release & Hydrochlorothiazide Tablets Each Extended Release Tablet Contains: Metoprolol Succinate Extended Release – 50 mg Hydrochlorothiazide – 12.5 mg Dosage Form: Extended Release Tablets Therapeutic Category: Antihypertensive Medication What is METAPROLATE H 50/12.5? METAPROLATE H 50/12.5 combines a beta-blocker and a thiazide diuretic to provide comprehensive blood pressure management. Metoprolol Succinate selectively blocks beta-1 receptors in the heart, reducing heart rate and decreasing the workload on the cardiovascular system. Hydrochlorothiazide acts as a diuretic by helping the body eliminate excess sodium and water through urine, lowering blood volume and contributing to reduced blood pressure. Together, these medicines offer a complementary approach to hypertension treatment and may help lower the risk of complications associated with persistently elevated blood pressure, including stroke, heart attack, and kidney damage, when used according to medical advice. Uses of METAPROLATE H 50/12.5 Healthcare professionals may prescribe METAPROLATE H 50/12.5 for: Management of essential hypertension Patients requiring combination antihypertensive therapy Long-term maintenance of healthy blood pressure levels Reducing cardiovascular risks associated with uncontrolled hypertension Supporting comprehensive blood pressure management alongside lifestyle modifications This medicine should always be used under the supervision of a qualified healthcare professional. Benefits of METAPROLATE H 50/12.5 Dual-Action Blood Pressure Control The combination of Metoprolol Succinate and Hydrochlorothiazide addresses hypertension through two different therapeutic pathways, providing effective blood pressure reduction. Sustained Drug Release The extended-release formulation delivers Metoprolol gradually over 24 hours, helping maintain stable therapeutic levels and consistent blood pressure control. Convenient Once-Daily Administration A single daily dose simplifies long-term treatment and may improve patient adherence to prescribed therapy. Supports Cardiovascular Health Maintaining optimal blood pressure with appropriate treatment can help reduce the likelihood of serious cardiovascular complications over time. Manufactured to High Quality Standards Every batch is produced using premium pharmaceutical ingredients under strict GMP guidelines, ensuring reliable quality, safety, and consistency. How METAPROLATE H 50/12.5 Works The effectiveness of METAPROLATE H 50/12.5 is based on the complementary actions of its two active ingredients. Metoprolol Succinate works by selectively blocking beta-1 adrenergic receptors in the heart, which helps: Slow the heart rate Reduce the force of cardiac contractions Decrease oxygen demand by the heart Lower blood pressure Hydrochlorothiazide works by promoting the removal of excess salt and water from the body through the kidneys. This helps: Reduce circulating blood volume Minimize fluid retention Lower blood pressure Improve overall cardiovascular function Together, these mechanisms contribute to effective and sustained blood pressure management. Dosage and Administration Take METAPROLATE H 50/12.5 exactly as prescribed by your physician. General recommendations include: Take one tablet daily or as directed by your healthcare provider. Swallow the extended-release tablet whole with water. Do not crush, chew, or split the tablet unless specifically instructed. It may be taken with or without food according to your doctor's advice. Take the medication at the same time each day to maintain consistent therapeutic levels. Continue treatment as prescribed, even if your blood pressure is well controlled, unless your doctor advises otherwise. Possible Side Effects As with any prescription medicine, some individuals may experience side effects, although many people tolerate the medication well. Commonly reported side effects include: Dizziness Tiredness or fatigue Slow heartbeat Headache Increased urination Nausea Low blood pressure Changes in electrolyte levels Seek immediate medical attention if you experience severe allergic reactions, breathing difficulties, fainting, persistent chest pain, or any other serious symptoms. Consult your healthcare provider if any side effect persists or becomes troublesome. Precautions and Warnings Before starting METAPROLATE H 50/12.5, inform your healthcare provider if you have: Heart rhythm abnormalities Heart failure Asthma or chronic respiratory disorders Diabetes mellitus Kidney or liver impairment Gout Electrolyte imbalance Thyroid disorders Allergy to Metoprolol, Hydrochlorothiazide, sulfonamide-derived medicines, or any ingredient in this product Regular monitoring of blood pressure, heart rate, kidney function, and electrolyte levels may be recommended during treatment. Storage Instructions To maintain product quality: Store in a cool and dry place. Protect from excessive heat, moisture, and direct sunlight. Keep the tablets in their original packaging until use. Store at the temperature indicated on the product label. Keep out of the reach of children. Why Choose METAPROLATE H 50/12.5? METAPROLATE H 50/12.5 is formulated to provide dependable blood pressure management with the convenience of a once-daily extended-release dosage form. Manufactured according to stringent pharmaceutical quality standards, it combines two trusted antihypertensive agents in a single tablet, supporting improved treatment adherence and long-term cardiovascular care. Key Advantages Extended-release formulation for sustained therapeutic action Combination of two proven antihypertensive medicines Convenient once-daily dosing High-quality manufacturing with strict quality assurance Reliable efficacy and consistent product performance Suitable for long-term hypertension management under medical supervision Frequently Asked Questions (FAQs) What is METAPROLATE H 50/12.5 prescribed for? It is prescribed for the treatment of high blood pressure in adults who require combination antihypertensive therapy. How does the extended-release formulation benefit patients? The extended-release technology gradually releases Metoprolol throughout the day, helping maintain consistent blood levels and prolonged blood pressure control. Can I discontinue METAPROLATE H 50/12.5 on my own? No. Beta-blockers should not be stopped suddenly, as abrupt discontinuation may increase cardiovascular risk. Always consult your healthcare provider before making any changes to your treatment. Can this medicine be used with other antihypertensive medications? Your doctor will determine whether additional blood pressure medicines are necessary based on your medical condition and treatment goals. How long should treatment continue? Hypertension is often a lifelong condition requiring continuous management. Continue taking METAPROLATE H 50/12.5 for the duration recommended by your healthcare professional, along with appropriate lifestyle modifications and regular medical follow-up.



![Acebrophylline and Erdosteine Tablets are a clinically trusted combination used in the management of chronic respiratory disorders associated with excessive mucus production, airway inflammation, and breathing difficulties. This dual-action formulation combines the bronchodilator and anti-inflammatory properties of Acebrophylline with the mucolytic and antioxidant benefits of Erdosteine, making it an effective treatment option for patients suffering from chronic obstructive pulmonary disease (COPD), chronic bronchitis, bronchial asthma, and other mucus-related respiratory conditions.
At [Your Company Name], we manufacture and supply premium-quality Acebrophylline and Erdosteine Tablets that comply with WHO-GMP standards and international pharmaceutical quality guidelines. Our formulations are trusted by healthcare professionals, hospitals, distributors, and pharmaceutical companies seeking reliable respiratory medicines.
Composition
Each film-coated tablet typically contains:
Acebrophylline – 200 mg
Erdosteine – 300 mg
Composition can be customized based on customer requirements and regulatory approvals.
How Acebrophylline and Erdosteine Tablets Work
The combination provides comprehensive respiratory support through complementary mechanisms.
Acebrophylline
Acebrophylline acts as a bronchodilator and anti-inflammatory agent. It helps relax bronchial muscles, widens the airways, improves airflow, and reduces inflammation, making breathing easier for patients with chronic respiratory diseases.
Erdosteine
Erdosteine is a powerful mucolytic agent that reduces the thickness and stickiness of mucus. It facilitates easier expectoration, reduces coughing, and provides antioxidant protection against airway damage caused by inflammation.
Together, these ingredients improve lung function, reduce respiratory symptoms, and enhance patient comfort.
Key Benefits of Acebrophylline and Erdosteine Tablets
Helps improve breathing by relaxing bronchial muscles
Effectively reduces thick mucus accumulation
Supports easier mucus clearance from the lungs
Reduces chronic cough and chest congestion
Helps manage COPD and chronic bronchitis symptoms
Provides antioxidant protection to respiratory tissues
Improves oxygen exchange and lung function
Enhances quality of life in patients with chronic respiratory disorders
Suitable for long-term respiratory disease management under medical supervision
Medical Uses of Acebrophylline and Erdosteine Tablets
Healthcare professionals commonly prescribe Acebrophylline and Erdosteine Tablets for:
Chronic Obstructive Pulmonary Disease (COPD)
Chronic Bronchitis
Bronchial Asthma
Respiratory Tract Infections with Excessive Mucus
Chronic Productive Cough
Airway Inflammation
Bronchiectasis
Smoking-related Respiratory Conditions
These tablets should always be used under the supervision of a qualified healthcare professional.
Advantages of the Acebrophylline and Erdosteine Combination
The combination therapy offers several clinical advantages over single-drug treatment.
Dual Mechanism of Action
It simultaneously opens the airways while reducing mucus thickness, providing comprehensive respiratory relief.
Improved Lung Function
Patients experience better airflow and enhanced breathing comfort due to bronchodilation and mucus clearance.
Reduced Frequency of Exacerbations
Regular use, as prescribed, may help decrease episodes of worsening respiratory symptoms in chronic lung diseases.
Better Patient Compliance
A fixed-dose combination simplifies treatment by reducing the need for multiple medications.
Recommended Dosage
The dosage of Acebrophylline and Erdosteine Tablets should be determined by a registered healthcare provider based on the patient's age, condition, and medical history.
General recommendations include:
Take the tablet after meals with water.
Swallow whole without crushing or chewing.
Follow the prescribed duration of therapy.
Do not exceed the recommended dose.
Possible Side Effects
Like all medicines, Acebrophylline and Erdosteine Tablets may cause side effects in some individuals.
Common side effects include:
Nausea
Stomach discomfort
Headache
Dizziness
Mild diarrhea
Dry mouth
Gastric irritation
Seek immediate medical attention if severe allergic reactions, breathing difficulty, or persistent adverse effects occur.
Precautions
Before using Acebrophylline and Erdosteine Tablets, patients should inform their healthcare provider if they have:
Liver disease
Kidney impairment
Gastric ulcer
Heart disease
Pregnancy or breastfeeding
Known allergy to methylxanthines or Erdosteine
Avoid self-medication and always follow professional medical advice.
Storage Instructions
Store below 25°C in a cool and dry place.
Protect from direct sunlight and moisture.
Keep out of reach of children.
Do not use after the expiry date.
Why Choose Our Acebrophylline and Erdosteine Tablets?
We are committed to delivering pharmaceutical products that meet international quality standards.
Our advantages include:
WHO-GMP Certified Manufacturing
ISO Certified Production Facilities
Stringent Quality Control
DCGI-Compliant Manufacturing
Competitive Pricing
Bulk Supply Capability
Third-Party Manufacturing Services
Private Label Packaging
Timely Global Deliveries
Custom Packaging Solutions
We serve pharmaceutical distributors, hospitals, government tenders, exporters, wholesalers, and healthcare institutions worldwide.
Frequently Asked Questions (FAQs)
1. What are Acebrophylline and Erdosteine Tablets used for?
Acebrophylline and Erdosteine Tablets are primarily used to treat respiratory conditions such as COPD, chronic bronchitis, asthma, and other diseases associated with excessive mucus production and airway obstruction.
2. How do Acebrophylline and Erdosteine Tablets work?
Acebrophylline relaxes the bronchial muscles and reduces inflammation, while Erdosteine breaks down thick mucus, making it easier to remove from the lungs.
3. Can Acebrophylline and Erdosteine Tablets treat chronic cough?
Yes. These tablets help relieve chronic productive cough by reducing mucus viscosity and improving airway clearance when prescribed by a healthcare professional.
4. Are Acebrophylline and Erdosteine Tablets safe for long-term use?
They may be prescribed for long-term management of chronic respiratory diseases, but treatment duration should always be determined by a physician.
5. Can these tablets be used for asthma?
Yes. Doctors may prescribe Acebrophylline and Erdosteine Tablets as part of asthma management when mucus accumulation and airway inflammation are significant.
6. Do Acebrophylline and Erdosteine Tablets have side effects?
Most side effects are mild and temporary, including nausea, headache, dizziness, stomach upset, and dry mouth. Serious reactions are uncommon but require immediate medical attention.
7. Should Acebrophylline and Erdosteine Tablets be taken before or after food?
They are generally recommended after meals to reduce the risk of stomach irritation. Follow your doctor's advice regarding dosage and timing.
8. Can smokers use Acebrophylline and Erdosteine Tablets?
Yes. Physicians often prescribe them to smokers suffering from chronic bronchitis, COPD, or mucus-related respiratory disorders.
9. Are Acebrophylline and Erdosteine Tablets available for third-party manufacturing?
Yes. We offer third-party manufacturing, private labeling, customized packaging, and bulk pharmaceutical supply for domestic and international markets.
10. Why buy Acebrophylline and Erdosteine Tablets from us?
Our products are manufactured in WHO-GMP-certified facilities using premium-quality raw materials, strict quality control processes, competitive pricing, and reliable global distribution, making us a trusted pharmaceutical manufacturing partner.
This version is optimized for buyer intent, includes keyword-rich headings and FAQs designed for Google Search and voice search, and naturally targets the primary keyword “Acebrophylline and Erdosteine Tablets” throughout the content without excessive keyword stuffing.](https://productimages.withfloats.com/tile/6a685f3db435445dbdc3d469.png)